ACCENDRA HEALTH INC/VA/ACHEarnings & Financial Report
NYSE
NextMar 31, 2026
ACH Q3 2025 Key Financial Metrics
Revenue
$697.3M
Gross Profit
$322.2M
Operating Profit
$26.5M
Net Profit
$-150.3M
Gross Margin
46.2%
Operating Margin
3.8%
Net Margin
-21.6%
YoY Growth
-74.4%
EPS
$-1.94
Financial Flow
ACCENDRA HEALTH INC/VA/ Q3 2025 Financial Summary
ACCENDRA HEALTH INC/VA/ reported revenue of $697.3M for Q3 2025, with a net profit of $-150.3M (-21.6% margin). Cost of goods sold was $375.1M, operating expenses totaled $295.7M.
Key Financial Metrics
| Total Revenue | $697.3M |
|---|---|
| Net Profit | $-150.3M |
| Gross Margin | 46.2% |
| Operating Margin | 3.8% |
| Report Period | Q3 2025 |
ACCENDRA HEALTH INC/VA/ Annual Revenue by Year
ACCENDRA HEALTH INC/VA/ annual revenue history includes year-by-year totals (for example, 2024 revenue was $10.7B).
| Year | Annual Revenue |
|---|---|
| 2024 | $10.7B |
| 2023 | $10.3B |
| 2022 | $10.0B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.66B | $2.61B | $2.67B | $2.72B | $2.70B | $2.63B | $681.9M | $697.3M |
| YoY Growth | 4.1% | 3.6% | 4.2% | 5.0% | 1.5% | 0.7% | -74.5% | -74.4% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $5.09B | $5.21B | $5.30B | $5.08B | $4.66B | $4.86B | $4.15B | $4.04B |
| Liabilities | $4.17B | $4.31B | $4.44B | $4.21B | $4.09B | $4.29B | $4.44B | $4.47B |
| Equity | $924.2M | $894.9M | $860.7M | $874.6M | $565.2M | $571.0M | $-281.0M | $-429.5M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $111.8M | $-53.0M | $116.1M | $27.3M | $71.0M | $-35.1M | $37.6M | $-172.5M |